Easier clinical trials, more investment in biotechnology. Biotech Act arrives in two parts

EU PERSPECTIVES - Biotech Act is seen by experts as a major opportunity to strengthen Europe's competitiveness in clinical research and innovation. Commission has now confirmed to EU Perspectives that the proposal will be presented in two parts and that the split is deliberate as 'different sectors within biotech need different approaches.' Read more

Biotech Act comes in two strands. Photo: Unsplash